206 related articles for article (PubMed ID: 28902919)
1. Factors associated with pulmonary impairment in HIV-infected South African adults.
Gupte AN; Wong ML; Msandiwa R; Barnes GL; Golub J; Chaisson RE; Hoffmann CJ; Martinson NA
PLoS One; 2017; 12(9):e0184530. PubMed ID: 28902919
[TBL] [Abstract][Full Text] [Related]
2. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort.
Martinson NA; Gupte N; Msandiwa R; Moulton LH; Barnes GL; Ram M; Gray G; Hoffmann C; Chaisson RE
PLoS One; 2014; 9(5):e96369. PubMed ID: 24831447
[TBL] [Abstract][Full Text] [Related]
3. Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study.
Kayongo A; Wosu AC; Naz T; Nassali F; Kalyesubula R; Kirenga B; Wise RA; Siddharthan T; Checkley W
COPD; 2020 Jun; 17(3):297-305. PubMed ID: 32462945
[TBL] [Abstract][Full Text] [Related]
4. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
[TBL] [Abstract][Full Text] [Related]
5. Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGE
Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; van Steenwijk RP; Drummond MB; Kirk GD; Reiss P;
Lancet Healthy Longev; 2021 Apr; 2(4):e202-e211. PubMed ID: 36098121
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
7. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort.
Drummond MB; Kirk GD; Astemborski J; Marshall MM; Mehta SH; McDyer JF; Brown RH; Wise RA; Merlo CA
Thorax; 2012 Apr; 67(4):309-14. PubMed ID: 22090038
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Nixon DE; Tedaldi E; Akolo C; Kityo C; Klinker H; La Rosa A; Connett JE;
HIV Med; 2015 Apr; 16 Suppl 1(0 0):119-28. PubMed ID: 25711330
[TBL] [Abstract][Full Text] [Related]
9. Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention.
Kranzer K; Lawn SD; Johnson LF; Bekker LG; Wood R
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):498-505. PubMed ID: 23572010
[TBL] [Abstract][Full Text] [Related]
10. Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.
Nash D; Wu Y; Elul B; Hoos D; El Sadr W;
AIDS; 2011 Jul; 25(12):1523-33. PubMed ID: 21750418
[TBL] [Abstract][Full Text] [Related]
11. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
13. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
15. Delirium in HIV-infected patients admitted to acute medical wards post universal access to antiretrovirals in South Africa.
Day C; Manning K; Abdullah F; James K; Grace L; April C; Calligaro G; Combrink M; Raubenheimer P; Peter JG
S Afr Med J; 2021 Oct; 111(10):974-980. PubMed ID: 34949292
[TBL] [Abstract][Full Text] [Related]
16. Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.
Gingo MR; Nouraie M; Kessinger CJ; Greenblatt RM; Huang L; Kleerup EC; Kingsley L; McMahon DK; Morris A
Ann Am Thorac Soc; 2018 Feb; 15(2):192-199. PubMed ID: 29313714
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
[TBL] [Abstract][Full Text] [Related]
18. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
[TBL] [Abstract][Full Text] [Related]
19. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
